These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3893841)

  • 21. Extreme pyrexia during bretylium administration.
    Perlman PE; Adams WG; Ridgeway NA
    Postgrad Med; 1989 Jan; 85(1):111, 114. PubMed ID: 2911533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacokinetics of ranitidine.
    Roberts CJ
    Clin Pharmacokinet; 1984; 9(3):211-21. PubMed ID: 6329583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pharmacokinetics of tenoxicam.
    Nilsen OG
    Clin Pharmacokinet; 1994 Jan; 26(1):16-43. PubMed ID: 8137596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of bretylium on rat cardiac muscle: the electrophysiological effects and its uptake and binding in normal and immunosympathectomized rat hearts.
    Namm DH; Wang CM; El-Sayad S; Copp FC; Maxwell RA
    J Pharmacol Exp Ther; 1975 Apr; 193(1):194-208. PubMed ID: 1133764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical suppression of refractory ventricular tachycardia with oral bretylium not predicted by electrophysiologic drug testing.
    Grubb BP; Luck JC; Bacaner M
    Chest; 1988 Aug; 94(2):430-2. PubMed ID: 3396427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents.
    Olkkola KT; Brunetto AV; Mattila MJ
    Clin Pharmacokinet; 1994 Feb; 26(2):107-20. PubMed ID: 8162655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of ion-pair formation on the pharmacokinetic properties of drugs. Pharmacokinetic interactions of bretylium and hexylsalicylic acid in rabbits.
    Amlacher R; Härtl A; Neubert R; Stöckel U; Wenzel K
    J Pharm Pharmacol; 1991 Nov; 43(11):794-7. PubMed ID: 1686909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical pharmacokinetics of sotalol.
    Hanyok JJ
    Am J Cardiol; 1993 Aug; 72(4):19A-26A. PubMed ID: 8346722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue distribution and plasma pharmacokinetics of UCN-01 at steady-state and following bolus administration in rats: influence of human alpha1-acid glycoprotein binding.
    Hedaya MA; Daoud SS
    Anticancer Res; 2001; 21(6A):4005-10. PubMed ID: 11911284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of the ion-pair-formation on the pharmacokinetic properties of drugs. Part 5: Influence of ion-pair-formation on elimination of bretylium and hexylsalicylic acid in rats.
    Neubert R; Hause C; Härtl A; Amlacher R
    Pharmazie; 1989 Sep; 44(9):630-1. PubMed ID: 2608709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amiodarone: a unique antiarrhythmic agent.
    Sloskey GE
    Clin Pharm; 1983; 2(4):330-40. PubMed ID: 6349912
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Arrhythmia and acute coronary syndrome suppression and cardiac resuscitation management with bretylium.
    Bacaner M; Dembo DH
    Am J Ther; 2009; 16(6):534-42. PubMed ID: 19542875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Crossover pharmacokinetic study of quinupramine in 6 subjects].
    Bouquet S; Lefebvre MA; Girault J; Fourtillan JB
    Encephale; 1982; 8(4):449-63. PubMed ID: 7151737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical pharmacokinetics of almitrine dimesylate].
    Bromet N; Singlas E
    Presse Med; 1984 Oct; 13(34):2071-7. PubMed ID: 6149534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and metabolism of zopiclone.
    Gaillot J; Heusse D; Hougton GW; Marc Aurele J; Dreyfus JF
    Int Pharmacopsychiatry; 1982; 17 Suppl 2():76-91. PubMed ID: 7188377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacokinetics of the angiotensin converting enzyme inhibitors. A review.
    Kubo SH; Cody RJ
    Clin Pharmacokinet; 1985; 10(5):377-91. PubMed ID: 2994938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and rats.
    Egorin MJ; Yuan ZM; Sentz DL; Plaisance K; Eiseman JL
    Cancer Chemother Pharmacol; 1999; 43(6):445-53. PubMed ID: 10321503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of bretylium tosylate on the in vivo fibrillating canine ventricle.
    Breznock EM; Kagan K; Hibser NK
    Am J Vet Res; 1977 Jan; 38(1):89-94. PubMed ID: 835872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.